FDA
-
-
-
-
-
-
-
AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum
-
-
-
-
-
-
-
AngioDynamics (ANGO) Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
-
-
-
-
-
-
-
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
-
-
-
-
-
-
-
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
-
-
-
-
-
-
-
AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PE
-
-
-
-
-
-
-
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
-
-
-
-
-
-
-
AngioDynamics (ANGO) Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems (MMSI) for $100 Million
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

